The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
KalVista Pharmaceuticals, Inc(NASDAQ:KALV) 
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HA...
Website: http://www.kalvista.com
Founded: 2004
Full Time Employees: 56
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
KalVista Pharmaceuticals Days Payable Outstanding ttm (DPO)
KalVista Pharmaceuticals Days Receivable Outstanding ttm (DSO)
KalVista Pharmaceuticals Days Inventory Outstanding ttm (DIO)
KalVista Pharmaceuticals Op Cashflow Per Share ttm
KalVista Pharmaceuticals Free Cashflow Per Share ttm
KalVista Pharmaceuticals Cash Per Share ttm
KalVista Pharmaceuticals P/S ratio ttm
KalVista Pharmaceuticals (GAAP) P/E ratio ttm
KalVista Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.